Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-008791
Filing Date
2014-02-13
Accepted
2014-02-13 20:25:39
Documents
1
Period of Report
2012-09-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v368365_4.html 4  
1 OWNERSHIP DOCUMENT v368365_4.xml 4 10996
  Complete submission text file 0001144204-14-008791.txt   12501
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507 304 292-2226
Protea Biosciences Group, Inc. (Issuer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address
ROBERSON ED (Reporting) CIK: 0001529381 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51474 | Film No.: 14609049